GGrantIndex
Sort

17,288 grants matching multiple sclerosis

Phase 1b Trial of stem cells in ALS

$577,888
Jonathan David Glass · Emory University · R01 · FY2014 · NS

Cortical correlates of gait in Parkinson's disease: impact of medication and cueing

$577,850
Martina Mancini · Oregon Health & Science University · R01 · FY2023 · HD

Progressive Multifocal Leukoenephalopathy: Endemic Viruses and Lethal Brain Disease

$577,779
Walter J Atwood · Brown University · R35 · FY2020 · NS

Tumor-Selective Delivery Approaches for Medulloblastoma

$577,523
Daniel Alan Heller · Sloan-Kettering Inst Can Research · R01 · FY2024 · NS

Development of a Multi-Modal Neuroimaging Biomarker for Amyotrophic Lateral Scler

$577,490
Robert C Welsh · University Of Michigan At Ann Arbor · R01 · FY2015 · NS

CAREER: Magnetic Stimulation and Myelination

$577,274
In Hong Yang · University Of North Carolina At Charlotte · · FY2023 · ENG

Interdisciplinary Immunology Training Program

$577,205
David G. Schatz · Yale University · T32 · FY2006 · AI

Development of a Multi-Modal Neuroimaging Biomarker for Amyotrophic Lateral Scler

$577,180
Bradley Foerster · University Of Michigan At Ann Arbor · R01 · FY2017 · NS

Cellular and humoral immune mechanisms underlying neurovascular dysfunction in autoimmune encephalitis

$577,118
Dritan Agalliu · Columbia University Health Sciences · R01 · FY2020 · MH

Cellular and humoral immune mechanisms underlying neurovascular dysfunction in autoimmune encephalitis

$576,972
Dritan Agalliu · Columbia University Health Sciences · R01 · FY2019 · MH

ICLIC-MS for Enhancing Outcomes Research and Clinical Care in Multiple Sclerosis

$576,893
Lisa F Barcellos · University Of California Berkeley · R01 · FY2022 · NR

Spatially Resolved Dynamics of Molecular Pathology and Intercellular Interactions in Amytrophic Lateral Sclerosis

$576,665
Hemali Phatnani · New York Genome Center · R01 · FY2021 · NS

The impact of sex and gender on disease progression, from developmental origins

$576,562
Margareta Pisarska · Cedars-Sinai Medical Center · R01 · FY2020 · AI

Blood Brain Barrier Changes Induced by Pain

$576,294
Thomas Paul Davis · University Of Arizona · R01 · FY2011 · NS

Neurofilaments, SOD1 and Motor Neuron Diseases

$576,188
Don W. Cleveland · Ludwig Institute For Cancer Res Ltd · R37 · FY2008 · NS

Neurofilaments, SOD1 and Motor Neuron Diseases

$576,176
Don W. Cleveland · Ludwig Institute For Cancer Res Ltd · R37 · FY2007 · NS

Molecular and genetic regulation of myelin capacity in the CNS

$576,142
Kelly R Monk · Oregon Health & Science University · R01 · FY2025 · NS

Development of Immunologic therapies against uveitis

$576,011
Charles E Egwuagu · National Eye Institute · ZIA · FY2025 · EY

Developmental effects of early hearing loss on auditory information processing

$575,922
Daniel J Tollin · University Of Colorado Denver · R01 · FY2018 · DC

The lipid amidase NAAA as a therapeutic target for Alzheimer's disease

$575,906
Daniele Piomelli · University Of California-Irvine · R01 · FY2024 · AG

Neuroprotective Effects of Minocycline in Lentiviral Inf

$575,876
M Christine Zink · Johns Hopkins University · R01 · FY2007 · MH

TAM Receptor Signaling in Neurodegenerative Disease

$575,699
Greg E Lemke · Salk Institute For Biological Studies · R56 · FY2018 · AG

Philadelphia Autoimmunity Center of Excellence

$575,678
Abdolmohamad Rostami · Thomas Jefferson University · U19 · FY2012 · AI

Metabolic predictors of disease outcomes in multiple sclerosis

$575,637
Kathryn C. Fitzgerald · Johns Hopkins University · R01 · FY2025 · NS

FreeSurfer Development, Maintenance, and Hardening

$575,580
Douglas Nowlin Greve · Massachusetts General Hospital · R01 · FY2022 · EB